These drugs in combination have synergistic action; for example the combination of an ACE inhibitor, beta-blocker and aldosterone receptor antagonist suppresses myocardial fibrosis in systolic heart failure.3 Therefore, combination therapy with drugs that block the SNS and RAAS systems may be the answer. Here, NR3C2 is linked to Myocardial fibrosis.